使用ALR2和RAGE的通道阻断剂的分子对接分析
Samreen Kazmi1, Surekha Challa2, Malini Devi Alaparthi3
1Department of Biotechnology, Mahatma Gandhi University, Narketpally Mandal, Telangana, India, 508003.
这项研究调查了糖尿病并发症的通道阻塞剂. 贝尼迪平和类似的1,4-二皮里丁通过与参与糖尿病二次并发症的关键酶结合,显示出药物发现的潜力.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 计算化学计算化学
背景情况:
- 糖尿病带来了重大的健康挑战,往往导致二次并发症.
- 先进的甘化终产物 (AGEs) 和阿尔多斯减少酶 (ALR2) 在这些并发症的发病过程中发挥着关键作用.
- 准ALR2和AGE受体 (RAGE) 是一种潜在的治疗策略.
研究的目的:
- 为了评估选择的通道阻断剂 (CCBs),特别是1,4-二皮里丁的结合效率,针对ALR2和RAGE.
- 确定潜在的候选药物来缓解与糖尿病相关的并发症.
主要方法:
- 进行了分子对接模拟.
- 这项研究使用了ALR2 (PDB代码:1Z3N) 和RAGE (PDB代码:3CJJ) 的晶体结构.
- 选择的1,4-二皮里丁通道阻断剂对这些目标进行了对接.
主要成果:
- 1,4-二皮里丁化合物证明有效地与ALR2和RAGE的活性部位结合.
- 贝尼迪平是一种特定的1,4-二二氨酸,表现出特别好的结合亲和力.
- 结果表明这些CCB对向酶的潜在抑制作用.
结论:
- 包括贝尼迪平 (Benidipine) 在内的1,4-二皮里丁衍生物显示出作为ALR2和RAGE的抑制剂的前景.
- 这些化合物在糖尿病并发症的药物发现计划中需要进一步调查和验证.
- 这些发现支持开发针对AGE和ALR2通路的新型治疗剂.
更多相关视频
08:46A "Dual-Addition" Calcium Fluorescence Assay for the High-Throughput Screening of Recombinant G Protein-Coupled Receptors
Published on: December 2, 2022
04:48A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
Published on: July 10, 2018
相关概念视频
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Antihypertensive Drugs: Action of Calcium Channel Blockers
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
